(English follows Japanese)
Japanese Title: Why are regulators, pharmaceutical companies, CROs around the world choosing JMP Clinical?
SAS Institute Inc. JMP Health and Life Sciences JMP Product Manager, Geoffrey Mann, Ph.D.
A group of clinical operations and biostatistics uses a variety of reports from JMP Clinical, including data consistency, Risk-Based Monitoring, and even subject profiles, to show how subjects, facilities , We will introduce whether you are evaluating abnormality of investigator or monitor.In addition, we show you that medical writers, medical monitors and medical experts can create safety and effectiveness contents in a comprehensive report and clinical assessment report that had been spending time in a short time .
Learn why regulatory agencies, pharmaceutical companies and CROs worldwide are choosing JMP Clinical.
SAS Institute Inc., JMP Health and Life Sciences JMP Product Manager, Geoffrey Mann, Ph.D.
We will demonstrate how clinical operations and biostatistics groups can evaluate global clinical trials for patients, site, investigator and monitor anomalies. Using a variety of reports from JMP Clinical, including Data Integrity, Risk-based monitoring and even patient profiles to evaluate the ongoing health of global clinical trials. We will also show how medical take writers, medical monitors and medical reviewers can create safety and efficacy content for clinical study reports and clinical review reports in a fraction of the time it used to take them.
This post originally written in Japanese and has been translated for your convenience. When you reply, it will also be translated back to Japanese.